Skip to main content

Table 2 Risk of recurrence and CA-125 changes after the treatment

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Variable HR 95%CI P
Change of CA-125 concentration
3 months after the treatment (U/ml)
< 0 1.00
0–5 1.25 0.80–1.93 0.3287
> 5 7.60 3.55–16.24 < 0.0001
Change of CA-125 concentration
6 months after the treatment (U/ml)
< 0 1.00
0–5 1.31 0.82–2.1 0.2598
> 5 5.29 2.99–9.35 < 0.0001